1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Baseline characteristics, procedure details, and complications according to reperfusion status^{^a}
Successful Reperfusion Status P Value
(mTICI 2b) Complete (mTICI 3)
No. of patients 109 113 
Age (mean) (yr) 69.0 ± 15.9 68.9 ± 14.7 .95
Men 41 (37.6) 55 (48.7) .096
Medical history 
    Hypertension 63 (57.8) 70 (62.0) .53
    Diabetes 18 (16.5) 21 (18.6) .69
    Dyslipidemia 32 (29.4) 37 (32.7) .59
    Current smoking^{^b} 20 (20.0) 22 (20.4) .95
NIHSS score (mean) 14.6 ± 6.3 13.7 ± 6.7 .30
Prestroke mRS ≥1 11 (10.1) 12 (10.6) .90
ASPECTS (median) (IQR) 8 (7–8) 8 (7–9) .32
Occlusion site 
    ICA 27 (24.8) 18 (15.9) .18
    MCA-M1 66 (60.5) 81 (71.7) 
    MCA-M2 16 (14.7) 14 (12.4) 
TICI initial (1 vs 0) 10 (9.2) 9 (8.0) .75
Favorable collateral flow^{^c} 79 (77.5) 97 (91.5) .005
Etiology 
    Cardioembolism 73 (67.0) 64 (56.7) .020
    Large-artery atherosclerosis 5 (4.6) 18 (15.9) 
    Other or undetermined 31 (28.4) 31 (27.4) 
Previous use of IV thrombolysis 77 (70.6) 73 (64.6) .34
General anesthesia 36 (33.0) 34 (30.1) .64
Onset to reperfusion time (median) (IQR) (min) 310 (260–361) 285 (225–340) .021
Onset-to-groin puncture 251 (208–300) 237 (191–292) .11
Groin puncture to reperfusion (median) (IQR) (min) 50 (31–68) 40 (24–58) .018
Total number of passes (median) (IQR) 2 (1–3) 1 (1–2) .0002
Periprocedural complication 13 (11.9) 9 (8.0) .32
Adjunctive treatment 7 (6.4) 3 (2.7) .21
↵a Values expressed as number (percentage) unless otherwise indicated.
↵b Fourteen missing data (9 in mTICI 2b and 5 in mTICI 3).
↵c Fourteen missing data (7 in mTICI 2b and 7 in mTICI 3).